4.7 Review

The aryl hydrocarbon receptor and the gut-brain axis

期刊

CELLULAR & MOLECULAR IMMUNOLOGY
卷 18, 期 2, 页码 259-268

出版社

CHIN SOCIETY IMMUNOLOGY
DOI: 10.1038/s41423-020-00585-5

关键词

Aryl hydrocarbon receptor; Autoimmune diseases; Infectious diseases; cancer

资金

  1. NIH [NS102807, ES02530, ES029136, AI126880]
  2. NMSS [RG-1902-33606]
  3. International Progressive MS Alliance [PA-1604-08459]
  4. Santander Universidades
  5. FundacAo Faculdade de Medicina (FFM), SAo Paulo, SP, Brazil

向作者/读者索取更多资源

The aryl hydrocarbon receptor (AHR) was originally identified as the receptor for dioxin and is now known to be a receptor for multiple physiological ligands, playing crucial roles in health and disease. AHR has been found to play a role in the gut-brain axis and could hold potential as a therapeutic target for immune-mediated diseases.
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor initially identified as the receptor for dioxin. Almost half a century after its discovery, AHR is now recognized as a receptor for multiple physiological ligands, with important roles in health and disease. In this review, we discuss the role of AHR in the gut-brain axis and its potential value as a therapeutic target for immune-mediated diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据